Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for <i>BRAF</i> V600-Mutant Unresectable or Metastatic Melanoma
Novartis Pharmaceuticals
Reinhard Dummer; Georgina V Long; Caroline Robert; Hussein A Tawbi; Keith T Flaherty; Paolo A Ascierto; Paul D Nathan; Piotr Rutkowski; Oleg Leonov; Caroline Dutriaux; Mario Mandalà; Paul Lorigan; Pier Francesco Ferrucci; Jean Jacques Grob; Nicolas Meyer; Helen Gogas; Daniil Stroyakovskiy; Ana Arance; Jan C Brase; Steven Green; Tomas Haas; Aisha Masood; Eduard Gasal; Antoni Ribas; Dirk Schadendorf